September 23rd, 2012

Introducing
The Rowboat
Quite Possibly The Holy Grail of Investing.
Step 1
: Sell the Put
( This is a Cash Covered Put, I have to have enough Cash to cover if the option is
exercised, this i
s also my maximum risk.)
ISIS @ $14.37
Isis Pharmaceuticals, Inc. (ISIS)
Sell to Open ISIS Oct 2012 $13.00 Put @ Market
currently $1.25 bid / $1.30 time
8.69%
return in 26 days
How to do this trade and commentary Video:
(Sign up for Auto

trading a
nd have this trade done for you automatically)
Sorry, no video’s this month
Isis Pharmaceuticals, Inc. engages in the discovery and development
of antisense drugs using antisense drug discovery platform. Its product
pipeline comprises 26 drugs to prima
rily treat cardiovascular,
metabolic, severe, and rare diseases, as well as cancer. The
companyflagship product, KYNAMRO, is an apo

B synthesis
inhibitor in development for the reduction of low

density lipoprotein
cholesterol. The company has collaborat
ion agreements with Biogen
Idec to develop and commercialize ISIS

SMNRx for the treatment of
spinal muscular atrophy; Bristol

Myers Squibb to discover, develop,
and commercialize antisense drugs targeting proprotein convertase
subtilisin/kexin type 9; and
Ortho

McNeil

Janssen Pharmaceuticals,
Inc. to discover, develop, and commercialize antisense drugs to treat
metabolic diseases, including type 2 diabetes. It also has a strategic
relationship with Eli Lilly and Company for the development of
LY2181308, an
antisense inhibitor of survivin; and a strategic alliance
with GlaxoSmithKline to develop new drugs against targets for rare
and serious diseases. The company was founded in 1989 and is
headquartered in Carlsbad, California.

Isis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad, CA 92010
Phone: 760

931

9200
Fax: 760

603

2700
Website:
http://www.isispharm.com
Remember, no more than 5 or 10% of your portfolio should ever go
into any one trade or position.

Step 2:
IF
it got Put to us,
Now we “Lock

in” a profit.
Sell
the
Covered Call
(Do not buy this stock just to sell the cove
red Call)
QCOR
@ $30.15
Questcor Pharmaceuticals, Inc. (QCOR)
Sell To Open QCOR October 2012 $44 Call @ Market
Currently .40c bid / .45c time value
History:
Cost basis
$35.00
per share.
Premiums collected:
.90c
per share
2.52%
Return in 13 months
$1
0,000 would have generated $252.00
actual trades:
08/20/2012 Sell To Open QCOR Sep12 35 Put $0.90
Questcor Pharmaceuticals, Inc., a biopharmaceutical company, provides prescription
drugs for the treatment of multiple sclerosis, nephrotic syndrome, and
infantile spasms
indications. It primarily offers H.P. Acthar Gel, an injectable drug for the treatment of
acute exacerbations of multiple sclerosis in adults; to induce a diuresis or a remission of
proteinuria in the nephrotic syndrome without uremia of t
he idiopathic type or that due to
lupus erythematosus; and as monotherapy for the treatment of infantile spasms in
infants and children under two years of age. The companys H.P. Acthar Gel also
focuses on rheumatology

related conditions, including collage
n diseases and rheumatic
disorders. In addition, it offers Doral for the treatment of insomnia. The company sells its
Acthar primarily to specialty pharmacies; and Doral to pharmaceutical wholesalers.
Questcor Pharmaceuticals, Inc. was founded in 1990 and
is headquartered in Anaheim,
California.
Questcor Pharmaceuticals, Inc.
1300 North Kellogg Drive
Suite D
Anaheim, CA 92807
Phone: 714

786

4200
Fax: 714

789

4229
Website:
http://www.questcor.com
Remember, no mo
re than 5 or 10% of your portfolio should ever go
into any one trade or position.

How did we do la
st Month? / Current/Older
Positions/History
This includes a running total for each position.
CLWR
@ $1.55
Hold:
Jan13 $5 Call still cooking
History:
Cost basis
$3.00
per share.
Premiums collected:
.85c
per share
28.33%
Return in 13 months
$10,00
0 would have generated $2833.00
actual trades:
06/18/2012 Sell To Open
CLWR Jan13 5 Call $0.05
09/19/2011 Sell To Open
CLWR Jan12 4 Call $0.30
09/16/2011 Buy To Close
CLWR Sep11 3 Put
09/16/2011 Buy CLWR

Option Assignment
$3.00
08/23/2011 Sell To Ope
n
CLWR Sep11 3 Put $0.50
Clearwire Corporation, through its subsidiaries, provides fourth generation
wireless broadband services in the United States. The company builds and
operates mobile broadband networks that offer high

speed mobile Internet
and resi
dential Internet access services. It serves retail customers through its
CLEAR brand. The company markets its products and services directly to
consumers, as well as through cellular retailers, consumer electronics stores,
satellite television dealers, and
computer sales and repair stores; and through
company

operated retail outlets. As of December 31, 2011, it had
approximately 1.3 million retail and 9.1 million wholesale subscribers. The company is headquartered in Bellevue, Washington. Clearwire Corporat
ion is
a subsidiary of Sprint HoldCo LLC.
DMND
@ $20.26
Put to us @ $32.00
Sell to Open Dec 2012 $30.00 Call @ Market
currently .25c bid / .28c time
History:
Cost basis
$32.00
per share.
Premiums collected:
1.95
per share
6%
Return in 7 months
$1
0,000 would have generated
$600.00
actual trades:
03/20/2012 Sell To Open DMND Jun12 33 Call $0.25
03/18/2012 Buy To Close EXPIRED DMND Mar12 32 CALL
02/21/2012 Sell To Open DMND Mar12 32 Call $0.20
02/17/2012 Buy DMND

Option Assignment $32.00
02/1
7/2012 Buy To Close
DMND Feb12 32 Put
02/06/2012 Sell To Open DMND Feb12 32 Put $1.50
Diamond Foods, Inc. engages in processing, marketing, and distributing snack
products. It provides snack products, including roasted, glazed and flavored nuts, trail
m
ixes, dried fruit, seeds, microwave popcorn products, and potato and tortilla chips
under the Emerald, Pop Secret, and Kettle brands. The company also offers culinary,
in

shell, and ingredient nuts under the Diamond of California brand name. It markets
its
culinary nuts to individuals who prepare meals or baked goods at home; and
ingredient nuts to food processors, restaurants, bakeries, and food service companies
and their suppliers. The company sells its products directly to national grocery, mass
merchan
diser, clubs, convenience stores, and drug store chains in the United States,
the United Kingdom, Germany, the Netherlands, Spain, Canada, South Korea, Turkey,
China, and Japan. Diamond Foods, Inc. was founded in 1912 and is based in San
Francisco, Califor
nia.
Diamond Foods, Inc.
600 Montgomery Street
13th Floor
San Francisco, CA 94111

2702
Phone: 415

445

7444
Website:
http://www.diamondfoods.com
ELN
@ $11.72

Hold
October $13 Call still cookin
g
History:
Cost basis
$12.00
per share.
Premiums collected:
1.20c
per share
10%
Return in 2 months
$10,000 would have generated
$1000.00
actual trades:
08/20/2012 Sell To Open
ELN Oct12 13 Call $0.35
07/23/2012 Sell To Open
ELN Aug12 12 Put $1.20
10%
return in 27 days
Elan Corporation, plc operates as a neuroscience

based biotechnology company in the
United States, Ireland, and internationally. It engages in research, development, and
commercial activities primarily in the areas of Alzheimerd
isease, ParkinsonHold
October $13 Call still cookin
g
History:
Cost basis
$12.00
per share.
Premiums collected:
1.20c
per share
10%
Return in 2 months
$10,000 would have generated
$1000.00
actual trades:
08/20/2012 Sell To Open
ELN Oct12 13 Call $0.35
07/23/2012 Sell To Open
ELN Aug12 12 Put $1.20
10%
return in 27 days
Elan Corporation, plc operates as a neuroscience

based biotechnology company in the
United States, Ireland, and internationally. It engages in research, development, and
commercial activities primarily in the areas of Alzheimerdisease, which
completed Phase II clinical
trial. In addition, the company focuses on the discovery and development of antibodies
to neo

epitope related targets for the treatment of a range of indications, including
amyloidosis, diabetes, cancer, and macular degeneration
; and drugs for oncology
related diseases comprising NEOD001 for the treatment of AL amyloidosis, as well as
focuses on developing ELND005 for bipolar disorder. Further, the company, through
collaboration agreement with Biogen Idec, Inc., develops and mark
ets Tysabri for the
treatment for Crohndisease. Additionally, Elan Corporation, plc, through a 49.9%
interest in Janssen AI, develops beta amyloid immunotherapies, including
bapineuzumab, ACC

001, and other compounds to treat Alzheimerdisease.
The
company also has collaboration agreements with Cambridge

Elan Centre, Dublin
Neurological Institute, University College Dublin, and Proteostasis. Elan Corporation, plc
was founded in 1969 and is headquartered in Dublin, Ireland.
Elan Corporation, plc
Tre
asury Building
Lower Grand Canal Street
Dublin, 2
Ireland
Phone: 353 1 709 4000
Fax: 353 1 709 4700
Website:
http://www.elan.com
FMCN
@ $23.76
Focus Media Holding Ltd
Hold
There is a bid to buy this company @ $
27 per share I have seen valuations of up to $38.00 per share, it would be prudent
to let this one cook for a while History:
Cost basis $
24.00
per share.
Premiums collected:
$ 1.50
per share
6.25
% Return in 6 months
$10,000 would have genera
ted $625.00
08/14/2012 Buy To Close
FMCN Oct12 27 Call

$0.50
07/23/2012 Sell To Open
FMCN Oct12 27 Call $0.40
05/21/2012 Sell To Open
FMCN Jul12 27 Call$0.40
04/23/2012 Sell To Open
FMCN May12 27 Call $0.45
04/20/2012 Buy FMCN

Option Assignment
$24.00
04/20/2012 Buy To Close
FMCN Apr12 24 Put
03/19/2012 Sell To Open
FMCN Apr12 24 Put $1.15
Focus Media Holding Limited, a multi

platform digital media company,
operates liquid crystal display (LCD) network using audiovisual digital
displays in China. T
he company engages in selling out

of

home advertising
time slots on its network of flat

panel digital advertising displays located in
high traffic areas of commercial, residential, and public buildings, such as
malls, hotels, and the lobbies of apartment b
uildings, as well as in

store
network. It provides advertising services on poster frames, on screens in
movie theatres, and on traditional outdoor billboards. As of December 31,
2011, the company had a LCD display network of approximately 155,751 flat

pane
l digital displays in approximately 114 cities; in

store network of
approximately 50,076 LCD displays in approximately 1,576 hypermarkets,
217 supermarkets, and 1,008 convenience stores; poster frame network of
approximately 445,126 non

digital frames and
LCD 1.0 picture frame
devices, as well as leased screen time in approximately 316 movie theaters,
including 2,190 screens. Focus Media Holding Limited is headquartered in
Central, Hong Kong.
GMCR
@ $26.76
(Put to us @ $40.00)
Sell to Open GMCR Dec 2012
$46 Call @ Market
currently
.30c bid / .33c time
History:
Cost basis $
40.00
per share.
Premiums collected:
$ 2.86
per share
7.15
% Return in 5 months $10,000 would have generated $2860.00
05/21/2012 Sell To Open
GMCR Sep12 41 Call $0.72
04/23/2
012 Sell To Open
GMCR May12 40 Put $2.14
Green Mountain Coffee Roasters, Inc. engages in the specialty coffee and
coffee maker business. The company sources, produces, and sells
approximately 200 varieties of coffee, cocoa, teas, and other beverages in K

Cup portion packs and coffee in traditional packaging, including whole bean
and ground coffee
selections in bags and ground coffee in fractional packs for
use in at

home (AH) and away

from

home (AFH). It sells its products
primarily in North America throug
h supermarkets, club stores, and
convenience stores; in restaurants and hospitality; and to office coffee
distributors, as well as directly to consumers through its Website. The
company also manufactures gourmet single

cup brewing systems and brewing
equip
ment. In addition, it sells AH single

cup brewers; accessories; and
coffee, tea, hot cocoa, and other beverages in K

Cup portion packs, as well as
offers other licensed roasters to retailers, department stores, and mass
merchandisers. Further, the company
sells AFH single

cup brewers to
distributors for use in offices. It provides its products under the Van Houtte,
Brûlerie St. Denis, Brûlerie Mont

Royal, and Orient Express brands, as well
as licensed Bigelow and Wolfgang Puck brands. The company was founde
d in
1981 and is based in Waterbury, Vermont.
Green Mountain Coffee Roasters Inc.
33 Coffee Lane
Waterbury, VT 05676
Phone: 802

244

5621
Fax: 802

244

5436
Website:
http://www.greenmountaincoffee.com
ONTY
@ $6.16
Hold
November $7.00 Calls, still cooking
History:
Cost basis
$5.00
per share.
Premiums collected:
1.95
per share
39%
Return in 8 months
$10,000 would have generated
$3900.00
actu
al trades:
05/21/2012 Sell To Open
ONTY Nov12 7 Call $0.05
03/20/2012 Sell To Open ONTY May12 6 Call $0.05
03/16/2012 Buy ONTY

Option Assignment
$5.00 03/16/2012 Buy To Close
ONTY Mar12 5 Put
02/21/2012 Sell To Open
ONTY Mar12 5 Put $0.70
02/19/2012 Buy To Close
EXPIRED ONTY FEB12 5 PUT
01/30/2012 Sell To Open
ONTY Feb12 5 Put $0.50
01/22/2012 Buy To Close
EXPIRED ONTY JAN12 5 PUT
01/09/2012 Sell To Open
ONTY Jan12 5 Put $0.30
Oncothyreon Inc.(ONTY), a clinical

stage biopharmaceutical
company, focuses
on the development of therapeutic products for the treatment of cancer. Its
primary product candidate, Stimuvax is in Phase III clinical trials for the
treatment of non

small cell lung cancer. The company also develops PX

866, a
small mole
cule that is in Phase II trials. In addition, it engages in the preclinical
development of ONT

10, a cancer vaccine. The company operates in Canada,
the United States, Barbados, and Europe. Oncothyreon Inc. was founded in
1985 and is headquartered in Seatt
le, Washington.
Oncothyreon Inc
2601 Fourth Avenue
Suite 500
Seattle, WA 98121
Phone: 206

801

2100
Fax: 206

801

2101
Website:
http://www.oncothyreon.com
PAAS
@ $22.46
Sell To Open PAAS January 2013
, $40 Call @ market
currently bid .10c / time .13c
History:
Cost basis
$36.00
per share.
Premiums collected:
$3.45
per share
Dividends : .
07c
Total:
$3.52
9.77%
Return in 15 months
$10,000 would have generated $977.00
actual trades:
01/30/2012Sell
To Open PAAS Jul12 36 Call $0.20
12/06/2011 PAAS

PAAS QUALIFIED DIVIDEND $.025
10/24/2011 Sell To Open
PAAS Jan12 36 Call $0.40
10/22/2011 Buy To Close
EXPIRED PAAS Oct11 36 Call
09/08/2011 PAAS

PAAS QUALIFIED DIVIDEND $.025
06/20/2011 Sell To Ope
n
PAAS Oct11 36 Call $0.80
06/19/2011 Buy To Close
EXPIRED PAAS JUN11 36 CALL
06/16/2011 PAAS QUALIFIED DIVIDEND $.025
05/23/2011 Sell To Open
PAAS Jun11 36 Call $0.50
05/20/2011 Buy PAAS

Option Assignment
$36.00
05/20/2011 Buy To Close
PAAS May11 36
Put $0.00
04/18/2011 Sell To Open
PAAS May11 36 Put $1.55
Pan American Silver Corp. engages in the exploration, development, extraction,
processing, production, refining, reclamation, and operation of silver properties. The
company also produces and se
lls gold, zinc, lead, and copper. As of April 27, 2011, it
had seven silver mining operations in Mexico, Peru, Argentina, and Bolivia. The
company was founded in 1979 and is headquartered in Vancouver, Canada.
Pan American Silver Corp.
625 Howe Street
Sui
te 1500
Vancouver, BC V6C 2T6
Phone: 604

684

1175
Fax: 604

684

0147
Website:
http://www.panamericansilver.com
PAY
@ $31.80
(Put to us @ $43.00)
HOLD
Oct12
$44 Call
Still cooking
History:
Cost basis
$43.00
per share.
Premiums collected:
$3.26
per share
7.58%
Return in 15 months
$10,000 would have generated
$758.00
actual trades:
06/18/2012 Sell To Open PAY Oct12 $44 Call $0.35
05/21/2012 Sell To Op
en
PAY Jun12 50 Call $1.00
04/16/2012 Sell To Open
PAY May12 57.5 Call $1.02
04/16/2012 Buy To Close
PAY Apr12 49 Call

$5.36
01/23/2012 Sell To Open
PAY Apr12 49 Call $0.40
01/22/2012 Buy To Close
EXPIRED PAY JAN12 49 CALL
10/31/2011 Sell To Open
PAY
Jan12 49 Call $0.90
10/31/2011 Buy To Close
PAY Jan12 46 Call

$1.90
10/24/2011 Sell To Open PAY Jan12 46 Call $1.10
10/22/2011 Buy To Close
EXPIRED PAY Oct11 42 Call
08/23/2011 Sell To Open
PAY Oct11 42 Call $0.60
08/21/2011 Buy To Close
EXPIRED PAY
AUG11 46
CALL
07/19/2011 Sell To Open
PAY Aug11 46 Call $1.05
07/17/2011 Buy To Close
EXPIRED PAY JUL11 44 CALL
06/20/2011 Sell To Open
PAY Jul11 44 Call $0.75
06/17/2011 Buy To Close
PAY Jun11 43 Put $0.00
06/17/2011 Buy PAY

Option Assignment $43.00
05
/23/2011 Sell To Open
PAY Jun11 43 Put $1.70
VeriFone Systems, Inc. designs, markets, and services electronic payment solutions that
enable secure electronic payments among consumers, merchants, and financial
institutions worldwide. The company provides c
ountertop electronic payment systems
that accept magnetic, smart card, and contactless/radio frequency identification cards;
and support credit, debit, check, electronic benefits transfer, and various pre

paid
products, as well as offers wireless system so
lutions. The company also provides
products for the point of sale applications, which include displays, user

friendly
interfaces, electronic cash registers (ECR) interfaces, durable key pads, and signature
capture functionality; and contactless/near field
communication (NFC) payment solutions
for consumer

activated transactions using contactless cards, tokens, or NFC enabled
mobile phones. In addition, it offers various products for petroleum companies, such as
integrated electronic payment systems that com
bine card processing, fuel dispensing,
and ECR functions, as well as secure payment systems for integration with petroleum
pump controllers and systems. Further, the company provides server

based transaction
products; secure payment hardware and software i
ntegration modules; and VeriShield
Protect, a solution that encrypts and protects consumer card data. Additionally, it offers
client services, including payment system consulting, deployment, on

site and
telephone

based installation and training, help desk
support, repairs, replacement of
impaired system solutions, asset tracking, and reporting; and project management
services. The company serves financial institutions, payment processors, petroleum
companies, retailers, government organizations, and health
care companies, as well as
independent sales organizations. The company was formerly known as VeriFone
Holdings, Inc. and changed its name to VeriFone Systems, Inc. in May 2010. The
company is headquartered in San Jose, California.
VeriFone Systems, Inc
2099 Gateway Place
Suite 600
San Jose, CA 95110
Phone: 408

232

7800
Fax: 408

232

7811
Website:
http://www.verifone.com
TPX
@ $30.10
Sell To Open TPX December 2012, $43 Call @ market
currently bid .25c / time .30c
Hist
ory:
Cost basis
$40.00
per share.
Premiums collected:
$1.00
per share
2.5%
Return in 4 months
$10,000 would have generated $400.00
actual trades:
06/18/2012 Sell To Open TPX Sep12 41 Call $0.05
06/16/2012 Buy TPX

Option Assignment $40.00
05/21/2012
Sell To Open TPX Jun12 40 Put $0.95
Tempur

Pedic International Inc. engages in the manufacture, marketing, and
distribution of bedding products in North America and internationally. It
offers mattresses, pillows, and adjustable bed bases, as well as vario
us
cushions and other comfort products. The company sells its products under
the TEMPUR and Tempur

Pedic brand names through furniture and bedding
retailers, and non

spring and department stores; direct response program,
Internet, and company

owned stores;
hospitals, nursing homes, healthcare
professionals, and medical retailers; and third party distributors. Tempur

Pedic International Inc. was founded in 1989 and is headquartered in
Lexington, Kentucky.
Tempur Pedic International Inc.
1713 Jaggie Fox Way
Lexington, KY 40511
Phone: 800

878

8889
Fax: 859

514

4422
Website:
http://www.tempurpedic.com
TRGT
@ $4.79
Hold
Take no action
There is no good option interest at this time.
History:
Cost bas
is
$12.50
per share.
Premiums collected:
$2.25
per share
18%
Return in 11 months
$10,000 would have generated $1800.00
actual trades:
02/21/2012 Sell To Open
TRGT May12 15 Call $0.25
11/28/2011 Sell To Open
TRGT Feb12 15 Call $0.40
11/18/2011 Buy To Clo
se
TRGT Nov11 12.5 Put
11/18/2011 Buy TRGT

Option Assignment $12.50
10/23/2011 Sell to Open TRGT Nov 11 $12.50 PUT $1.60
Targacept, Inc., a biopharmaceutical company, engages in the design,
discovery, and development of novel Neuronal Nicotinic Recep
tors (NNR)
Therapeutics for the treatment of diseases and disorders of the nervous
system. Its lead program, TC

5214, a nicotinic channel modulator, is in Phase
3 clinical trials as an adjunct treatment for major depressive disorder (MDD)
and in Phase 2b c
linical trial for switch monotherapy in patients with MDD.
The company s novel small molecule product candidates under Phase 2
clinical development include TC

5619 for treating negative symptoms and
cognitive dysfunction in schizophrenia, attention deficit
/hyperactivity
disorder, and Alzheimer s disease; AZD3480 as a treatment for mild to
moderate Alzheimer s disease; AZD1446 as a treatment for Alzheimer s
disease; and TC

6987 for the treatment of inflammatory disorders, including
asthma and Type 2 diabetes
. It has a collaborative research and license
agreement with AstraZeneca AB for the development and commercialization
of AZD3480, TC

5214, and TC

5619; and a product development and
commercialization agreement with SmithKline Beecham Corporation to
discove
r, develop, and market product candidates that selectively target
specified NNR subtypes in specified therapeutic focus areas. The company
was founded in 1997 and is based in Winston

Salem, North Carolina.
Targacept, Inc.
200 East First Street
Suite 300
Winston

Salem, NC 27101

4165
Phone: 336

480

2100
Fax: 336

480

2107
Website:
http://www.targacept.com
ZNGA
@ $3.24
Hold
Take no action
There is no good option interest at this time.
History:
Cost basis
$14.00
per s
hare.
Premiums collected:
$2.05
per share
14.64%
Return in 7 months
$10,000 would have generated
$1464.00
actual trades:
03/19/2012 Sell To Open
ZNGA Apr12 16 Call $0.20
03/18/2012 Buy To Close EXPIRED ZNGA MAR12 15 CALL
02/21/2012 Sell To Open
ZNGA
Mar12 15 Call $0.40
02/17/2012 Buy
ZNGA

Option Assignment $14.00
02/17/2012 Buy To Close
ZNGA Feb12 14 Put
02/06/2012Sell To Open ZNGA Feb12 14 Put$1.55
Zynga Inc. develops, markets, and operates online social games as
live services on the Internet, s
ocial networking sites, and mobile
platforms. The company offers its online social games under the
CityVille, Zynga Poker, FarmVille, CastleVille, FrontierVille, Mafia
Wars, Word with Friends, Hidden Chronicles, Zynga Bingo, Scramble
With Friends, Slingo,
and Dream Heights names. Its games are
available on various platforms, including Facebook and other social
networks, as well as mobile platforms, such as Apple iOS and Google
Android worldwide. The company was formerly known as Zynga Game
Network Inc. and
changed its name to Zynga Inc. in November 2010.
Zynga Inc. was founded in 2007 and is headquartered in San
Francisco, California.
Zynga, Inc.
699 Eighth Street
San Francisco, CA 94103
Phone: 855

449

9642
Fax: 302

636

5454
Website:
http://www.zynga.com
Quote of the Month:

You only have to do a very few things right in your life so long
as you don’t do too many things wrong. “
~
Warren Buffet
Until Next Time
Brad Lee
The Options Oracle

Summary:
Sell to Open ISIS Oct 2012 $13.00 Put
@ Market
Sell to Open DMND Dec 2012 $30
Call @ Market
Sell to Open GMCR Dec 2012 $46
Call @ Market
Sell To Open PAAS Jan 2013 $40
Call @ market
Sell To Open TPX Dec 2012, $43 Call
@ market
Sell To Open Q
COR October 2012
$44 Call @ Market
Greetings and Welcome aboard to all
new subscribers.
Congrats to all with successful trades.
Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto

trading is for you. Your accoun
t will
automatically do whatever I do.
You are still in control, you set the limits
either a dollar amount or a percentage.
Go to:
https://theoptionsoracle.com/auto-trading/

Ask The O
racle”
webinar Sunday 8 pm
est
to explain this newsletter, or other
questions you might have.
Here is the link
http://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
e
ducational business/investment
purposes.
Check with your Licensed
Professional adviser
https://theoptionsoracle.com/auto-trading/
Disclosure: These are my actual
trades.
Your subscriptio
n fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed
Professional adviser Company News
Auto Trading is now active!
Don’t want to be bothered doing the
trades?
Auto

trading is for you. Your account
will automatically do whatever I do.
You are sti
ll in control, you set the
limits either a dollar amount or a
percentage.
Go to the main site, the Auto

trade link
is on the site
https://theoptionsoracle.com/
We will be doing a webinar
Sunday 8 pm est to explain this
newsletter.
Here is t
he link
http://www.anymeeting.com/MoneyMedic1
Disclosure: These are my actual
trades.
Your subscription fee may be 100%
TAX DEDUCTIBLE if used for
educational business/investment
purposes.
Check with your Licensed

Professional adviser

Options involve risk and are not suitable
fo
r all investors. Prior to trading options,
you must be approved for options
trading and read the Characteristics and
Risks of Standardized Options.
Copies of this document may also be
obtained from your broker, from any
exchange on which options are trade
d, by
placing an order online, or by contacting
the Options Clearing Corporation directly
at 1 N. Wacker Dr., Suite 500, Chicago, IL
60606. (1

888

678

4667).
Brad Lee AKA “The Options Oracle”
and “The Money Medic” is an
individual investor who does not
manage money for any financial
institution.You are purchasing the list
of stocks that he uses to select options
contracts he feels will return him the
highest, safest profits. Brad is not a
broker, or financial adviser. He is a
remarkable investor who has
developed a successful strategy for
himself, and is willing to share some of
his magic with you. We urge you to
paper trade these picks and learn how
to develop a strategy that is
appropriate for you. Thank You.
We make no recommendations on
investment
and we do not provide
financial, tax or legal advice. Content
and tools are provided for educational
and informational purposes only.
Disclaimer
Trading or investment in stocks, futures &
options, and commodity are subject to potential
market risks. Y
ou can use our materials or
recommendations for educational purposes, this
is not intended as Trading or Investment advice.
We are not financial advisers. We cannot
provide any advice as to whether or not options
or our trading ideas are suitable investmen
ts for your particular financial situation. We are in the
business of publishing our trade ideas for market
analysis only. We highly recommend that our
subscribers review their trading allocation with a
qualified registered financial adviser/planner.
Leg
al Disclaimer: we do not exist to render and
do not give legal, tax, economic or investment
advice and disclaims all liability for the actions or
inaction taken or not as a result of
communications from or to its members, officers,
directors, employees and
contractors. Each
individual should consult his/her own counsel,
accountant and other advisors as to legal, tax,
economic, investment and related matters
concerning any type of investments.
This email and any files transmitted with it are
solely intende
d for the use of the addressee(s)
and may contain information that is confidential
and privileged. If you receive this email in error,
please advise us by return email immediately.
Please also disregard the contents of the email,
delete it and destroy any
copies immediately.